Ghent University Academic Bibliography

Show Sort by

Your filters: cql: jcr.category exact "CLINICAL NEUROLOGY"

Add to list
- Conference Paper
- C3
- open access
Beyond the periphery : central auditory processing in parkinsonian disorders

Evelien De Groote (UGent) , Kim De Keyser (UGent) , Annelies Bockstael (UGent) , Dick Botteldooren (UGent) , Patrick Santens (UGent) and Miet De Letter (UGent)

(2019) MOVEMENT DISORDERS. 34(Suppl. 2). p.S335-S336
Add to list
The influence of one session of low frequency rTMS on pre-supplementary motor area metabolites in late stage Parkinson's disease

Anja Flamez, Wietse Wiels, Peter Van Schuerbeek, Johan De Mey, Jacques De Keyser and Chris Baeken (UGent)

(2019) CLINICAL NEUROPHYSIOLOGY. 130(8). p.1292-1298
Add to list
Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmus

Anja K. Mayer, Muhammad Mahajnah, Mervyn G. Thomas, Yuval Cohen, Adib Habib, Martin Schulze, Gail D. E. Maconachie, Basamat Almoallem Mohammed (UGent) , Elfride De Baere (UGent) , Birgit Lorenz, et al.

(2019) BRAIN. 142(6). p.1528-1534
Add to list
- Journal Article
- open access
Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.

S Muppidi, K Utsugisawa, M Benatar, H Murai, RJ Barohn, I Illa, S Jacob, J Vissing, TM Burns, JT Kissel, et al.

(2019) Muscle Nerve. 60(1).
Add to list
- Journal Article
- open access
FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

TW Rattay, T Lindig, J Baets, K Smets, T Deconinck, AS Söhn, K Hörtnagel, KN Eckstein, S Wiethoff, J Reichbauer, et al.

(2019) Brain. 142(6).
Add to list
- Journal Article
- open access
Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review.

Antoon Meylemans (UGent) and Jan De Bleecker (UGent)

(2019) Acta Neurol Belg. 119(4).
Add to list
- Journal Article
- open access
Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.

MG Hanna, UA Badrising, O Benveniste, TE Lloyd, M Needham, H Chinoy, M Aoki, PM Machado, C Liang, KA Reardon, et al.

(2019) Lancet Neurol. 18(9).
Add to list
- Journal Article
- open access
Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability.

R Cacace, B Heeman, S Van Mossevelde, A De Roeck, J Hoogmartens, P De Rijk, H Gossye, K De Vos, W De Coster, M Strazisar, et al.

(2019) Acta Neuropathol. 137(6).
Add to list
- Journal Article
- open access
Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.

H Murai, A Uzawa, Y Suzuki, T Imai, H Shiraishi, H Suzuki, M Okumura, F O'Brien, JJ Wang, KP Fujita, et al.

(2019) J Neurol Sci. 407.
Add to list
- Journal Article
- open access
Healthcare utilization at the end of life in people dying from amyotrophic lateral sclerosis: A retrospective cohort study using linked administrative data.

A Maetens, L Deliens, Jan De Bleecker (UGent) , A Caraceni, M De Ridder, K Beernaert and J Cohen

(2019) J Neurol Sci. 406.

Academic Bibliography

Beyond the periphery : central auditory processing in parkinsonian disorders

The influence of one session of low frequency rTMS on pre-supplementary motor area metabolites in late stage Parkinson's disease

Homozygous stop mutation in AHR causes autosomal recessive foveal hypoplasia and infantile nystagmus

Long-term safety and efficacy of eculizumab in generalized myasthenia gravis.

FAHN/SPG35: a narrow phenotypic spectrum across disease classifications.

Current evidence for treatment with nusinersen for spinal muscular atrophy: a systematic review.

Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial.

Loss of DPP6 in neurodegenerative dementia: a genetic player in the dysfunction of neuronal excitability.

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study.

Healthcare utilization at the end of life in people dying from amyotrophic lateral sclerosis: A retrospective cohort study using linked administrative data.

Contents

Support

Contact